Shopping Cart 0
Cart Subtotal
USD 0

Acerus Pharmaceuticals Corp (ASP) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Acerus Pharmaceuticals Corp (ASP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses on providing men's and women's health. The company uses its proprietary drug delivery technology platforms, which include a bioadhesive nasal gel and the TriVair Deposition/Dispersion System, for the delivery of its products. Its product portfolio includes Estrace, which is approved in Canada for relief from menopausal symptoms; and Natesto, a testosterone nasal gel, which is approved by the US FDA for the treatment of male hypogonadism and filed for approval in Canada. Acerus is also developing Tefina (testosterone nasal gel) for women with female sexual dysfunction. Acerus is headquartered in Mississauga, Ontario, Canada.

Acerus Pharmaceuticals Corp Key Recent Developments

Jun 05,2018: Acerus Announces Resignation Of Luc Mainville As Director

May 29,2018: Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest

May 15,2018: Acerus Reports First Quarter 2018 Financial Results

Apr 23,2018: Acerus Secures Additional CDN USD2M under the Quantius Loan Facility

Apr 10,2018: Acerus Announces Settlement of Melnyk Litigation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Acerus Pharmaceuticals Corp-Key Facts 6

Acerus Pharmaceuticals Corp-Key Employees 7

Acerus Pharmaceuticals Corp-Key Employee Biographies 8

Acerus Pharmaceuticals Corp-Major Products and Services 9

Acerus Pharmaceuticals Corp-History 10

Acerus Pharmaceuticals Corp-Company Statement 12

Acerus Pharmaceuticals Corp-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

Acerus Pharmaceuticals Corp-Business Description 15

Acerus Pharmaceuticals Corp-Corporate Strategy 16

Acerus Pharmaceuticals Corp-SWOT Analysis 17

SWOT Analysis-Overview 17

Acerus Pharmaceuticals Corp-Strengths 17

Acerus Pharmaceuticals Corp-Weaknesses 18

Acerus Pharmaceuticals Corp-Opportunities 19

Acerus Pharmaceuticals Corp-Threats 20

Acerus Pharmaceuticals Corp-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Acerus Pharmaceuticals Corp, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

May 29, 2018: Acerus Acquires Canadian Rights to Novel Pain Relief Product for Gynecological Procedures from Pharmanest 32

May 15, 2018: Acerus Reports First Quarter 2018 Financial Results 33

Apr 23, 2018: Acerus Secures Additional CDN USD2M under the Quantius Loan Facility 35

Apr 10, 2018: Acerus Announces Settlement of Melnyk Litigation 36

Mar 29, 2018: Acerus Announces Executive Leadership Change 37

Mar 02, 2018: Acerus Comments on Decision Regarding Litigation 2018 38

Dec 07, 2017: Acerus Appoints Mr. Mark Lievonen to its Board of Directors 39

Nov 07, 2017: Acerus Reports Third Quarter 2017 Financial Results 40

Oct 02, 2017: Acerus Announces Executive Leadership Change 42

Aug 11, 2017: Acerus Reports Second Quarter 2017 Financial Results 43

Section 6-Appendix 45

Methodology 45

Ratio Definitions 45

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Acerus Pharmaceuticals Corp, Performance Chart (2013-2017) 26

Acerus Pharmaceuticals Corp, Ratio Charts 28

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Acerus Pharmaceuticals Corp, Key Facts 6

Acerus Pharmaceuticals Corp, Key Employees 7

Acerus Pharmaceuticals Corp, Key Employee Biographies 8

Acerus Pharmaceuticals Corp, Major Products and Services 9

Acerus Pharmaceuticals Corp, History 10

Acerus Pharmaceuticals Corp, Subsidiaries 13

Acerus Pharmaceuticals Corp, Key Competitors 21

Acerus Pharmaceuticals Corp, Ratios based on current share price 22

Acerus Pharmaceuticals Corp, Annual Ratios 23

Acerus Pharmaceuticals Corp, Annual Ratios (Cont...1) 24

Acerus Pharmaceuticals Corp, Annual Ratios (Cont...2) 25

Acerus Pharmaceuticals Corp, Interim Ratios 27

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Acerus Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Acerus Pharmaceuticals Corp, Recent Deals Summary 31

Currency Codes 45

Capital Market Ratios 45

Equity Ratios 46

Profitability Ratios 46

Cost Ratios 47

Liquidity Ratios 47

Leverage Ratios 48

Efficiency Ratios 48

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Acerus Pharmaceuticals Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Upsher-Smith Laboratories Inc

Sprout2 Inc

Paladin Labs Inc.

Invaron Pharmaceuticals Inc

Allergan Plc